These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

97 related items for PubMed ID: 4088538

  • 1. Neurofilamentous axonopathies. The neurotoxicology of acrylamides, hexacarbons, IDPN and carbon disulfide. Proceedings of the Second International Conference on Neurotoxicology of Selected Chemicals. September 11-15, 1983, Chicago, Illinois, U.S.A.
    Neurotoxicology; 1985; 6(4):1-98. PubMed ID: 4088538
    [No Abstract] [Full Text] [Related]

  • 2. Covalent crosslinking of neurofilaments in the pathogenesis of n-hexane neuropathy.
    Graham DG, Anthony DC, Szakál-Quin G, Gottfried MR, Boekelheide K.
    Neurotoxicology; 1985; 6(4):55-63. PubMed ID: 3937075
    [Abstract] [Full Text] [Related]

  • 3. Toxic neurofilamentous axonopathies and fast anterograde axonal transport. II. The effects of single doses of neurotoxic and non-neurotoxic diketones and beta, beta'-iminodipropionitrile (IDPN) on the rate and capacity of transport.
    Sickles DW.
    Neurotoxicology; 1989; 10(1):103-11. PubMed ID: 2475834
    [Abstract] [Full Text] [Related]

  • 4. Pathogenesis of experimental giant neurofilamentous axonopathies: a unified hypothesis based on chemical modification of neurofilaments.
    Sayre LM, Autilio-Gambetti L, Gambetti P.
    Brain Res; 1985 Sep; 357(1):69-83. PubMed ID: 2412663
    [Abstract] [Full Text] [Related]

  • 5. Axonal transport of neurofilament proteins in IDPN neurotoxicity.
    Griffin JW, Parhad I, Gold B, Price DL, Hoffman PN, Fahnestock K.
    Neurotoxicology; 1985 Sep; 6(4):43-53. PubMed ID: 2418391
    [Abstract] [Full Text] [Related]

  • 6. Morphological studies of toxic distal axonopathy.
    Schaumburg HH.
    Neurobehav Toxicol; 1979 Sep; 1 Suppl 1():187-8. PubMed ID: 299577
    [Abstract] [Full Text] [Related]

  • 7. Toxic neurofilamentous axonopathies -- accumulation of neurofilaments and axonal degeneration.
    Llorens J.
    J Intern Med; 2013 May; 273(5):478-89. PubMed ID: 23331301
    [Abstract] [Full Text] [Related]

  • 8. Toxic neurofilamentous axonopathies and fast anterograde axonal transport. III. Recovery from single injections and multiple dosing effects of acrylamide and 2,5-hexanedione.
    Sickles DW.
    Toxicol Appl Pharmacol; 1991 May; 108(3):390-6. PubMed ID: 2020966
    [Abstract] [Full Text] [Related]

  • 9. Toxic neurofilamentous axonopathies and fast anterograde axonal transport. IV. In vitro analysis of transport following acrylamide and 2,5-hexanedione.
    Sickles DW.
    Toxicol Lett; 1992 Jul; 61(2-3):199-204. PubMed ID: 1641866
    [Abstract] [Full Text] [Related]

  • 10. Alterations in the neutral proteinase activities of central and peripheral nervous systems of acrylamide-, carbon disulfide-, or 2,5-hexanedione-treated rats.
    Gupta RP, Abou-Donia MB.
    Mol Chem Neuropathol; 1996 Sep; 29(1):53-66. PubMed ID: 8887940
    [Abstract] [Full Text] [Related]

  • 11. Neurotoxic properties of certain aliphatic hexacarbons.
    Spencer PS, Schaumburg HH.
    Proc R Soc Med; 1977 Jan; 70(1):37-9. PubMed ID: 859830
    [No Abstract] [Full Text] [Related]

  • 12. Toxic neurofilamentous axonopathies and fast anterograde axonal transport. I. The effects of single doses of acrylamide on the rate and capacity of transport.
    Sickles DW.
    Neurotoxicology; 1989 Jan; 10(1):91-101. PubMed ID: 2475836
    [Abstract] [Full Text] [Related]

  • 13. Neurotoxicology in the fetus and child. Proceedings of the Fourth International Neurotoxicology Conference. September 9-13, 1985, Little Rock, Arkansas, U.S.A.
    Neurotoxicology; 1986 Jan; 7(2):1-678. PubMed ID: 3785747
    [No Abstract] [Full Text] [Related]

  • 14. The morphology of carbon disulfide neurotoxicity.
    Gottfried MR, Graham DG, Morgan M, Casey HW, Bus JS.
    Neurotoxicology; 1985 Jan; 6(4):89-96. PubMed ID: 3003629
    [Abstract] [Full Text] [Related]

  • 15. Tissue culture and neurotoxicology.
    Hooisma J.
    Neurobehav Toxicol Teratol; 1982 Jan; 4(6):617-22. PubMed ID: 7170018
    [Abstract] [Full Text] [Related]

  • 16. Neurotoxicology and risk assessment. Seventh International Neurotoxicology Conference. Little Rock, Arkansas, September 18-21, 1989. Proceedings.
    Neurotoxicology; 1990 Jan; 11(2):177-390. PubMed ID: 1978269
    [No Abstract] [Full Text] [Related]

  • 17. Neurotoxicology of lead. Reviews and recent advances. Proceedings of the Lead Neurotoxicity Symposium, September 20-21, 1982, Chicago, Illinois.
    Neurotoxicology; 1984 Jan; 5(3):1-361. PubMed ID: 6542974
    [No Abstract] [Full Text] [Related]

  • 18. Cytoskeletal disorganization induced by local application of beta, beta'-iminodipropionitrile and 2,5-hexanedione.
    Griffin JW, Fahnestock KE, Price DL, Cork LC.
    Ann Neurol; 1983 Jul; 14(1):55-61. PubMed ID: 6684411
    [Abstract] [Full Text] [Related]

  • 19. Studies on the morphologic alterations of axonal membraneous organelles in neurofilamentous neuropathies.
    Sahenk Z, Mendell JR.
    Brain Res; 1983 Jun 06; 268(2):239-47. PubMed ID: 6191830
    [Abstract] [Full Text] [Related]

  • 20. Biomarker research in neurotoxicology: the role of mechanistic studies to bridge the gap between the laboratory and epidemiological investigations.
    Costa LG.
    Environ Health Perspect; 1996 Mar 06; 104 Suppl 1(Suppl 1):55-67. PubMed ID: 8722110
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 5.